Soy Tomato Juice to Improve Outcomes in Pancreatitis
RecruitingPhase 1, Phase 2NCT07447687
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
This goal of this clinical trial is to see if people with recurrent acute pancreatitis or chronic pancreatitis can tolerate and regularly drink a tomato juice beverage. Researchers will also measure inflammation and ask participants to report how they feel. Everyone in the study will receive the tomato juice drink, and both participants and researchers will know what is being taken. The investigators expect the drink will be well tolerated, may lower inflammation, and may improve participant-reported symptoms and quality of life.
Study details
- Official title
- Soy Tomato Juice to Improve Outcomes in Pancreatitis (the STOP Trial): a Phase 1/2 Single Arm Trial
- Conditions
- Recurrent Acute Pancreatitis
- Chronic Pancreatitis
- Interventions
- Dietary supplement: Soy-tomato juice product
- Dietary supplement: Will include a soy-tomato juice product to be consumed during the 4 week intervention phase. A total of about 12 ounces (administered in two small cans) of the juice will be consumed
- Sponsor
- Ohio State University
- Collaborators
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Start date
- 2026-02
- Primary completion
- 2027-11
- Sex
- All
- Age range
- from 18 Years to 80 Years
- Results posted
- No results posted in this snapshot
- Countries
- United States
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Diagnosis of definite chronic pancreatitis (CP) or recurrent acute pancreatitis (RAP) * Patients should be able to fully understand and participate in all aspects of the study Exclusion Criteria: * Episode of acute pancreatitis, hospitalization, or endoscopic/surgical intervention within 30 days of enrollment * Chronic, daily use of systemic immunomodulatory medication for any indication * Previous allergic reaction to soy or tomato products * Known pregnancy
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT07447687